Europe Viral Vector Production Market Size, Share & Trends Analysis Report By Type (Adeno-Associated Viral Vectors, Lentiviral Vectors, Adenoviral Vectors, Retroviral Vectors, and Others), By Indication, By Application, By Country and Growth Forecast, 2023 - 2030

The Europe Viral Vector Production Market would witness market growth of 18.9% CAGR during the forecast period (2023-2030).

The increase in demand for gene therapy and the growth in awareness about its potential benefits among healthcare professionals and patients have also fueled the expansion of the viral vector production market. There is greater recognition of the crucial role of viral vectors in delivering therapeutic genes. This increased demand and awareness have driven investments in viral vector production and propelled market growth. On the other hand, the high cost of production and stringent regulatory requirements pose significant challenges to the growth of the viral vector production market.

Furthermore, the complex and intricate manufacturing processes in producing viral vectors can be costly, requiring specialized facilities, equipment, and skilled personnel. In addition, stringent regulatory frameworks, including Good Manufacturing Practices (GMP), are in place to ensure viral vectors' safety, efficacy, and quality. The cost and regulatory hurdles create barriers to market entry, particularly for smaller companies, and can impede the overall growth and scalability of the market.

Europe has witnessed a growing pipeline of gene therapies targeting various diseases, including rare genetic disorders, cancers, and neurodegenerative conditions. European companies quickly adopt advanced technologies in bioprocessing, automation, and analytical tools. These technological advancements enhance the efficiency and quality of viral vector production processes. Due to the aforementioned factors the market growth will drive in this region.

The Germany market dominated the Europe Viral Vector Production Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $224.1 Million by 2030. The UK market is exhibiting a CAGR of 17.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 19.8% during (2023 - 2030).

Free Valuable Insights: The Global Viral Vector Production Market will Hit USD 3.9 Billion by 2030, at a CAGR of 19.1%

Based on Type, the market is segmented into Adeno-Associated Viral Vectors, Lentiviral Vectors, Adenoviral Vectors, Retroviral Vectors, and Others. Based on Indication, the market is segmented into Cancer, Genetic Disorders, Infectious Diseases, and Others. Based on Application, the market is segmented into Gene Therapy, and Vaccinology. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

• Andelyn Biosciences, Inc.
• Charles River Laboratories International, Inc.
• Danaher Corporation
• FinVector Oy (Ferring Ventures S/A)
• Thermo Fisher Scientific, Inc.
• Novartis AG
• Takara Bio Inc. (Takara Holdings Inc.)
• Avid Bioservices, Inc.
• Oxford Biomedica plc
• Lonza Group Ltd.

Europe Viral Vector Production Market Report Segmentation

By Type

• Adeno-Associated Viral Vectors
• Lentiviral Vectors
• Adenoviral Vectors
• Retroviral Vectors
• Others

By Indication

• Cancer
• Genetic Disorders
• Infectious Diseases
• Others

By Application

• Gene Therapy
• Vaccinology

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Viral Vector Production Market, by Type
1.4.2 Europe Viral Vector Production Market, by Indication
1.4.3 Europe Viral Vector Production Market, by Application
1.4.4 Europe Viral Vector Production Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis

Chapter 4. Strategies Deployed in Viral Vector Production Market

Chapter 5. Europe Viral Vector Production Market, by Type
5.1 Europe Adeno-Associated Viral Vectors Market, by Country
5.2 Europe Lentiviral Vectors Market, by Country
5.3 Europe Adenoviral Vectors Market, by Country
5.4 Europe Retroviral Vectors Market, by Country
5.5 Europe Others Market, by Country

Chapter 6. Europe Viral Vector Production Market, by Indication
6.1 Europe Cancer Market, by Country
6.2 Europe Genetic Disorders Market, by Country
6.3 Europe Infectious Diseases Market, by Country
6.4 Europe Others Market, by Country

Chapter 7. Europe Viral Vector Production Market, by Application
7.1 Europe Gene Therapy Market, by Country
7.2 Europe Vaccinology Market, by Country

Chapter 8. Europe Viral Vector Production Market, by Country
8.1 Germany Viral Vector Production Market
8.1.1 Germany Viral Vector Production Market, by Type
8.1.2 Germany Viral Vector Production Market, by Indication
8.1.3 Germany Viral Vector Production Market, by Application
8.2 UK Viral Vector Production Market
8.2.1 UK Viral Vector Production Market, by Type
8.2.2 UK Viral Vector Production Market, by Indication
8.2.3 UK Viral Vector Production Market, by Application
8.3 France Viral Vector Production Market
8.3.1 France Viral Vector Production Market, by Type
8.3.2 France Viral Vector Production Market, by Indication
8.3.3 France Viral Vector Production Market, by Application
8.4 Russia Viral Vector Production Market
8.4.1 Russia Viral Vector Production Market, by Type
8.4.2 Russia Viral Vector Production Market, by Indication
8.4.3 Russia Viral Vector Production Market, by Application
8.5 Spain Viral Vector Production Market
8.5.1 Spain Viral Vector Production Market, by Type
8.5.2 Spain Viral Vector Production Market, by Indication
8.5.3 Spain Viral Vector Production Market, by Application
8.6 Italy Viral Vector Production Market
8.6.1 Italy Viral Vector Production Market, by Type
8.6.2 Italy Viral Vector Production Market, by Indication
8.6.3 Italy Viral Vector Production Market, by Application
8.7 Rest of Europe Viral Vector Production Market
8.7.1 Rest of Europe Viral Vector Production Market, by Type
8.7.2 Rest of Europe Viral Vector Production Market, by Indication
8.7.3 Rest of Europe Viral Vector Production Market, by Application

Chapter 9. Company Profiles
9.1 Andelyn Biosciences, Inc.
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.2.2 Geographical Expansions:
9.2 Charles River Laboratories International, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Recent strategies and developments:
9.2.4.1 Product Launches and Product Expansions:
9.2.4.2 Acquisition and Mergers:
9.2.4.3 Geographical Expansions:
9.2.5 SWOT Analysis
9.3 Danaher Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 FinVector Oy (Ferring Ventures S/A)
9.4.1 Company Overview
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.5.2 Geographical Expansions:
9.5.6 SWOT Analysis
9.6 Novartis AG
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 Takara Bio Inc. (Takara Holdings Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Avid Bioservices, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Recent strategies and developments:
9.8.3.1 Geographical Expansions:
9.9 Oxford Biomedica plc
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.10. Lonza Group Ltd.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis

TABLE 1 Europe Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 2 Europe Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 3 Europe Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 4 Europe Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 5 Europe Adeno-Associated Viral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 6 Europe Adeno-Associated Viral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 7 Europe Lentiviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 8 Europe Lentiviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 9 Europe Adenoviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 10 Europe Adenoviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 11 Europe Retroviral Vectors Market, by Country, 2019 - 2022, USD Million
TABLE 12 Europe Retroviral Vectors Market, by Country, 2023 - 2030, USD Million
TABLE 13 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 14 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 15 Europe Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 16 Europe Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 17 Europe Cancer Market, by Country, 2019 - 2022, USD Million
TABLE 18 Europe Cancer Market, by Country, 2023 - 2030, USD Million
TABLE 19 Europe Genetic Disorders Market, by Country, 2019 - 2022, USD Million
TABLE 20 Europe Genetic Disorders Market, by Country, 2023 - 2030, USD Million
TABLE 21 Europe Infectious Diseases Market, by Country, 2019 - 2022, USD Million
TABLE 22 Europe Infectious Diseases Market, by Country, 2023 - 2030, USD Million
TABLE 23 Europe Others Market, by Country, 2019 - 2022, USD Million
TABLE 24 Europe Others Market, by Country, 2023 - 2030, USD Million
TABLE 25 Europe Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 26 Europe Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 27 Europe Gene Therapy Market, by Country, 2019 - 2022, USD Million
TABLE 28 Europe Gene Therapy Market, by Country, 2023 - 2030, USD Million
TABLE 29 Europe Vaccinology Market, by Country, 2019 - 2022, USD Million
TABLE 30 Europe Vaccinology Market, by Country, 2023 - 2030, USD Million
TABLE 31 Europe Viral Vector Production Market, by Country, 2019 - 2022, USD Million
TABLE 32 Europe Viral Vector Production Market, by Country, 2023 - 2030, USD Million
TABLE 33 Germany Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 34 Germany Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 35 Germany Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 36 Germany Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 37 Germany Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 38 Germany Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 39 Germany Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 40 Germany Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 41 UK Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 42 UK Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 43 UK Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 44 UK Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 45 UK Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 46 UK Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 47 UK Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 48 UK Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 49 France Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 50 France Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 51 France Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 52 France Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 53 France Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 54 France Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 55 France Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 56 France Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 57 Russia Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 58 Russia Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 59 Russia Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 60 Russia Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 61 Russia Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 62 Russia Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 63 Russia Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 64 Russia Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 65 Spain Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 66 Spain Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 67 Spain Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 68 Spain Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 69 Spain Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 70 Spain Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 71 Spain Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 72 Spain Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 73 Italy Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 74 Italy Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 75 Italy Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 76 Italy Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 77 Italy Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 78 Italy Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 79 Italy Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 80 Italy Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 81 Rest of Europe Viral Vector Production Market, 2019 - 2022, USD Million
TABLE 82 Rest of Europe Viral Vector Production Market, 2023 - 2030, USD Million
TABLE 83 Rest of Europe Viral Vector Production Market, by Type, 2019 - 2022, USD Million
TABLE 84 Rest of Europe Viral Vector Production Market, by Type, 2023 - 2030, USD Million
TABLE 85 Rest of Europe Viral Vector Production Market, by Indication, 2019 - 2022, USD Million
TABLE 86 Rest of Europe Viral Vector Production Market, by Indication, 2023 - 2030, USD Million
TABLE 87 Rest of Europe Viral Vector Production Market, by Application, 2019 - 2022, USD Million
TABLE 88 Rest of Europe Viral Vector Production Market, by Application, 2023 - 2030, USD Million
TABLE 89 Key Information – Andelyn Biosciences, Inc.
TABLE 90 key information – Charles River Laboratories International, Inc.
TABLE 91 Key Information – Danaher Corporation
TABLE 92 Key Information – FinVector Oy
TABLE 93 Key Information – Thermo Fisher Scientific, Inc.
TABLE 94 Key Information – Novartis AG
TABLE 95 Key Information – Takara Bio Inc.
TABLE 96 Key Information – Avid Bioservices, Inc.
TABLE 97 Key Information – Oxford Biomedica PLC
TABLE 98 Key Information –Lonza Group Ltd.

List of Figures
FIG 1 Methodology for the research
FIG 2 Europe Viral Vector Production Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Viral Vector Production Market
FIG 4 Porter’s Five Forces Analysis – viral vector production market
FIG 5 Europe Viral Vector Production Market share, by Type, 2022
FIG 6 Europe Viral Vector Production Market share, by Type, 2030
FIG 7 Europe Viral Vector Production Market, by Type, 2019 - 2030, USD Millio
FIG 8 Europe Viral Vector Production Market share, by Indication, 2022
FIG 9 Europe Viral Vector Production Market share, by Indication, 2030
FIG 10 Europe Viral Vector Production Market, by Indication, 2019 - 2030, USD Million
FIG 11 Europe Viral Vector Production Market share, by Application, 2022
FIG 12 Europe Viral Vector Production Market share, by Application, 2030
FIG 13 Europe Viral Vector Production Market, by Application, 2019 - 2030, USD Million
FIG 14 Europe Viral Vector Production Market share, by Country, 2022
FIG 15 Europe Viral Vector Production Market share, by Country, 2030
FIG 16 Europe Viral Vector Production Market, by Country, 2019 - 2030, USD Million
FIG 17 Recent strategies and developments: Andelyn Biosciences, Inc.
FIG 18 Recent strategies and developments: Charles River Laboratories International, Inc.
FIG 19 Swot Analysis: Charles River Laboratories International, Inc.
FIG 20 SWOT Analysis: Danaher Corporation
FIG 21 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 22 Swot Analysis: Thermo Fisher Scientific, Inc.
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Recent strategies and developments: Oxford Biomedica plc
FIG 25 Swot Analysis: Lonza Group Ltd.